Literature DB >> 413821

Possible beta-lactamase activities detectable in infective clinical specimens.

G Masuda, S Tomioka.   

Abstract

Biological beta-lactam antibiotic-inactivating activities were detected in bacteriuria and suppurating pleural fluids. Clinical specimens were sterilized with membrane filters and the amounts of ampicillin and/or cephalothin which were being inactivated by 1 ml of each filtrate were determined. In general, filtrates which originally yielded Klebsiella sp. tended to show activity against ampicillin; whereas those yielding Enterobacter sp. and Pseudomonas aeruginosa showed activity against cephalothin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 413821     DOI: 10.7164/antibiotics.30.1093

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

1.  Quantitative assessment of bactericidal activities of beta-lactam antibiotics by agar plate method.

Authors:  G Masuda; S Tomioka
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

2.  β-Lactamase-Producing Bacteria in Upper Respiratory Tract Infections.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

3.  Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes.

Authors:  R J Boon; A S Beale
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

Review 4.  Antimicrobial drugs used in the management of anaerobic infections in children.

Authors:  I Brook
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

5.  Direct and indirect pathogenicity of Branhamella catarrhalis.

Authors:  I Brook
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 6.  The role of beta-lactamase-producing-bacteria in mixed infections.

Authors:  Itzhak Brook
Journal:  BMC Infect Dis       Date:  2009-12-14       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.